Jean-Michel Dogné Selected Research

seratrodast

2/2002	Therapeutic potential of thromboxane inhibitors in asthma.
1/2002	Thromboxane A2 inhibition: therapeutic potential in bronchial asthma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Michel Dogné Research Topics

Disease

19	Thrombosis (Thrombus) 01/2021 - 03/2003
17	Neoplasms (Cancer) 01/2018 - 08/2004
15	COVID-19 01/2022 - 01/2020
10	Hemorrhage 01/2018 - 06/2008
8	Activated Protein C Resistance (APC Resistance) 03/2022 - 12/2012
8	Atherosclerosis 01/2018 - 12/2005
7	Myocardial Infarction 06/2014 - 04/2004
7	Inflammation (Inflammations) 11/2013 - 08/2004
6	Thrombocytopenia (Thrombopenia) 12/2021 - 06/2010
5	Venous Thromboembolism 01/2021 - 01/2013
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2020 - 05/2016
5	Hypoxia (Hypoxemia) 11/2013 - 11/2006
4	Hemolysis 10/2018 - 01/2014
4	Stroke (Strokes) 01/2014 - 01/2005
4	Shock 07/2006 - 08/2003
4	Asthma (Bronchial Asthma) 03/2006 - 01/2002
3	Infections 04/2022 - 03/2021
3	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 07/2019 - 09/2015
3	Disseminated Intravascular Coagulation 02/2017 - 03/2014
3	Pain (Aches) 08/2015 - 01/2007
3	Pulmonary Embolism 01/2006 - 09/2004
3	Pulmonary Hypertension 01/2005 - 08/2003
2	Drug-Related Side Effects and Adverse Reactions 01/2018 - 01/2008
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2017 - 07/2014
2	Atrial Fibrillation 10/2014 - 01/2014
2	Acute Kidney Injury (Acute Renal Failure) 02/2014 - 01/2014
2	Tics (Tic) 01/2014 - 03/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 04/2010 - 09/2009
2	Epilepsy (Aura) 12/2008 - 01/2007
2	Hypertension (High Blood Pressure) 01/2008 - 12/2005
2	Septic Shock (Toxic Shock Syndrome) 07/2006 - 01/2006
1	Virus Diseases (Viral Diseases) 04/2022

Drug/Important Bio-Agent (IBA)

12	ThromboxanesIBA 01/2016 - 01/2002
10	Thrombin FDA Link 03/2022 - 03/2012
9	AnticoagulantsIBA 02/2021 - 06/2008
7	Biomarkers (Surrogate Marker)IBA 05/2020 - 01/2005
6	AntibodiesIBA 04/2022 - 01/2020
6	Protein CIBA 03/2022 - 01/2014
6	AntigensIBA 01/2022 - 01/2020
6	RivaroxabanIBA 02/2021 - 12/2012
6	Dabigatran FDA Link 02/2021 - 05/2012
6	Heparin (Liquaemin)FDA LinkGeneric 12/2018 - 06/2010
6	N- terbutyl- N'- (2- (4'- methylphenylamino)- 5- nitrobenzenesulfonyl)ureaIBA 01/2016 - 01/2004
6	Carbonic Anhydrases (Carbonic Anhydrase)IBA 06/2011 - 03/2005
6	Protein Isoforms (Isoforms)IBA 02/2009 - 01/2006
5	bcr-abl Fusion ProteinsIBA 05/2020 - 05/2016
5	Pharmaceutical PreparationsIBA 01/2018 - 01/2006
5	Biological ProductsIBA 11/2017 - 12/2005
5	Thromboxane A2 (A2, Thromboxane)IBA 09/2009 - 01/2002
5	IsoenzymesIBA 02/2009 - 03/2005
4	Contraceptive Agents (Contraceptives)IBA 03/2022 - 01/2020
4	SteroidsIBA 03/2022 - 01/2020
4	Immunoglobulin G (IgG)IBA 12/2021 - 11/2020
4	ponatinibIBA 01/2020 - 05/2016
4	Thromboxane Receptors (Thromboxane Receptor)IBA 01/2016 - 01/2002
4	ferric chlorideIBA 04/2005 - 05/2004
3	Indicators and Reagents (Reagents)IBA 03/2022 - 05/2012
3	BNT162 VaccineIBA 09/2021 - 01/2021
3	VaccinesIBA 09/2021 - 01/2021
3	apixabanIBA 02/2021 - 01/2014
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2005
3	nilotinib FDA Link 01/2020 - 01/2017
3	Dasatinib (BMS 354825)FDA Link 01/2020 - 01/2017
3	eculizumab FDA Link 07/2019 - 09/2015
3	Thromboplastin (Tissue Factor)IBA 02/2017 - 01/2013
3	IsoprostanesIBA 09/2009 - 12/2005
3	Epoprostenol (Prostacyclin)FDA LinkGeneric 09/2009 - 12/2005
3	EnzymesIBA 06/2008 - 01/2007
3	SulfonamidesIBA 06/2008 - 11/2006
3	Arachidonic Acid (Vitamin F)IBA 06/2006 - 01/2002
3	ProstaglandinsIBA 03/2006 - 01/2002
3	LeukotrienesIBA 03/2006 - 01/2002
2	Intravenous Immunoglobulins (IVIG)FDA Link 12/2021 - 12/2021
2	Neutralizing AntibodiesIBA 11/2021 - 01/2021
2	Combined Oral ContraceptivesIBA 08/2021 - 01/2021
2	AntithrombinsIBA 02/2021 - 12/2020
2	Protein SIBA 02/2021 - 12/2020
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021 - 12/2020
2	Fibrinogen (Factor I)FDA Link 12/2020 - 12/2012
2	Blood Coagulation Factors (Coagulation Factor)IBA 12/2020 - 12/2012
2	Imatinib Mesylate (Gleevec)FDA Link 01/2018 - 01/2017
2	MicroRNAs (MicroRNA)IBA 01/2018 - 11/2017
2	Complement System Proteins (Complement)IBA 08/2017 - 09/2015
2	Dacarbazine (DIC)FDA LinkGeneric 02/2017 - 03/2014
2	Therapeutic UsesIBA 06/2011 - 09/2009
2	Carbonic Anhydrase IXIBA 06/2011 - 11/2006
2	Vasodilator Agents (Vasodilators)IBA 04/2010 - 09/2009
2	Carbonic Anhydrase InhibitorsIBA 06/2008 - 01/2007
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2008 - 01/2007
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2008 - 01/2007
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2008 - 01/2006
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2008 - 01/2006
2	Urea (Carbamide)FDA LinkGeneric 09/2004 - 05/2004
2	ozagrelIBA 02/2002 - 01/2002
2	ramatrobanIBA 02/2002 - 01/2002
2	seratrodastIBA 02/2002 - 01/2002
1	Messenger RNA (mRNA)IBA 09/2021

Therapy/Procedure

8	Therapeutics 08/2021 - 08/2003
2	Duration of Therapy 01/2021 - 12/2020
2	Intravenous Administration 01/2017 - 10/2009